Mesa Laboratories, Inc. (NASDAQ:MLAB) has received a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $250.00.
Several equities analysts recently issued reports on the company. TheStreet upgraded Mesa Laboratories from a “c+” rating to a “b” rating in a research note on Tuesday, July 30th. Zacks Investment Research cut Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. BidaskClub cut Mesa Laboratories from a “hold” rating to a “sell” rating in a research note on Thursday. Evercore ISI assumed coverage on Mesa Laboratories in a research note on Monday, August 26th. They set an “outperform” rating and a $250.00 price objective on the stock. Finally, ValuEngine lowered Mesa Laboratories from a “hold” rating to a “sell” rating in a research report on Thursday, October 10th.
MLAB traded down $4.37 during trading hours on Tuesday, hitting $213.21. 43,226 shares of the stock were exchanged, compared to its average volume of 43,084. The stock has a 50-day simple moving average of $228.52 and a 200-day simple moving average of $231.51. Mesa Laboratories has a 12 month low of $169.80 and a 12 month high of $268.47. The stock has a market cap of $948.27 million, a price-to-earnings ratio of 39.70 and a beta of 0.26. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.59 and a quick ratio of 1.26.
The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 29th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend is Wednesday, November 27th. Mesa Laboratories’s dividend payout ratio is presently 11.92%.
Hedge funds and other institutional investors have recently modified their holdings of the business. Aperio Group LLC acquired a new stake in Mesa Laboratories in the second quarter worth $27,000. LS Investment Advisors LLC acquired a new stake in Mesa Laboratories in the second quarter worth $28,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in Mesa Laboratories in the third quarter worth $35,000. Bank of Montreal Can increased its position in Mesa Laboratories by 1,982.4% in the second quarter. Bank of Montreal Can now owns 354 shares of the medical instruments supplier’s stock worth $86,000 after buying an additional 337 shares during the period. Finally, Quantamental Technologies LLC increased its position in Mesa Laboratories by 61.9% in the second quarter. Quantamental Technologies LLC now owns 489 shares of the medical instruments supplier’s stock worth $119,000 after buying an additional 187 shares during the period. 81.31% of the stock is currently owned by hedge funds and other institutional investors.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.
Featured Article: What are the components of an earnings report?
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.